Condition
Retinal Vein Occlusion clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Retinal Vein Occlusion clinical trials that are recruiting, at sites in 4 countries (most in United States (3), China (1), United Kingdom (1)). By phase: Phase 2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Retinal Vein Occlusion clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ANXV (Annexin A5) infusions for non-proliferative diabetic retinopathy and retinal vein occlusion | Phase 2 | London | Recruiting | Dec 2, 2025 |
| Watching a short video before anti-VEGF eye injections | — | Hangzhou, Zhejiang | Recruiting | Jun 3, 2025 |
| Using advanced imaging to analyze retinal vascular diseases | — | Baltimore, Maryland | Recruiting | Aug 10, 2020 |
| MB-102 versus fluorescein sodium for retinal angiography imaging | Early Phase 1 | Ann Arbor, Michigan | Recruiting | Jul 5, 2019 |
| Measuring sCD160 in eye fluids and blood to look for links with ischemic retinal diseases | — | Reims | Recruiting | Sep 21, 2018 |
| Biorepository for studying retinal diseases | — | Bethesda, Maryland | Recruiting | Dec 21, 2011 |
All recruiting trials (6)
-
ANXV (Annexin A5) infusions for non-proliferative diabetic retinopathy and retinal vein occlusion
This will test whether short daily infusions of ANXV can be given safely and help improve vision or reduce the need for rescue medication in adults with recent-onset non-proliferative diabetic retinopathy or retinal vein occlusion.
-
Watching a short video before anti-VEGF eye injections
This trial will test whether watching a brief procedural video before a first anti-VEGF intravitreal injection helps people with retinal diseases feel less anxious and have fewer or smaller subconjunctival hemorrhages.
-
Using advanced imaging to analyze retinal vascular diseases
This study is testing new imaging techniques to see how they can help doctors understand and track the progress of retinal diseases like diabetic retinopathy in both healthy people and those affected by these conditions.
-
MB-102 versus fluorescein sodium for retinal angiography imaging
This trial will test whether the new dye MB-102 produces safe, high-quality retinal angiography images in adults with healthy eyes or retinal vascular disease compared with standard fluorescein sodium.
-
Measuring sCD160 in eye fluids and blood to look for links with ischemic retinal diseases
This project tests whether sCD160 levels in the eye and blood are linked to ischemic retinal disease in adults having eye surgery.
-
Biorepository for studying retinal diseases
This study is collecting health information and samples from people with and without eye diseases to see how these conditions develop and respond to treatments.
Related topics
Quick answers
How many Retinal Vein Occlusion clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), China (1 trial), United Kingdom (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.